297 related articles for article (PubMed ID: 29996899)
1. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
3. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
Fischer C; Deutsch TM; Feisst M; Rippinger N; Riedel F; Hartkopf AD; Brucker SY; Domschke C; Fremd C; Michel L; Burwinkel B; Schneeweiss A; Turchinovich A; Wallwiener M
Arch Gynecol Obstet; 2022 Sep; 306(3):875-885. PubMed ID: 35237856
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer.
Papadaki C; Stoupis G; Tsalikis L; Monastirioti A; Papadaki M; Maliotis N; Stratigos M; Mastrostamatis G; Mavroudis D; Agelaki S
Oncotarget; 2019 Jan; 10(9):966-981. PubMed ID: 30847025
[TBL] [Abstract][Full Text] [Related]
7. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
[TBL] [Abstract][Full Text] [Related]
8. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
Papadaki C; Thomopoulou K; Monastirioti A; Koronakis G; Papadaki MA; Rounis K; Vamvakas L; Nikolaou C; Mavroudis D; Agelaki S
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924670
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
11. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
12. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
14. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
Fahim SA; Abdullah MS; Espinoza-Sánchez NA; Hassan H; Ibrahim AM; Ahmed SH; Shakir G; Badawy MA; Zakhary NI; Greve B; El-Shinawi M; Götte M; Ibrahim SA
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708601
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
17. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.
Yang IP; Tsai HL; Miao ZF; Huang CW; Kuo CH; Wu JY; Wang WM; Juo SH; Wang JY
J Transl Med; 2016 Apr; 14(1):108. PubMed ID: 27126129
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
19. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]